Continuation and selection of antihypertensives before and after non-cardiac surgery could reduce risks
Continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers before non-cardiac surgery is linked to a reduced risk of postoperative mortality and functional decline, according to researchers from ...
Oct 2, 2025
0
0









